<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Inclusion complexes formed with a host–guest molecule may exhibit improved chemical or biological properties compared to the host molecule alone. Such inclusion may: (i) improve aqueous solubility, dissolution, and bioavailability [
 <xref rid="B24-ijms-20-00642" ref-type="bibr" class="xref">24</xref>]; (ii) increase the physicochemical stability of drugs and improve the shelf life of drugs [
 <xref rid="B3-ijms-20-00642" ref-type="bibr" class="xref">3</xref>,
 <xref rid="B24-ijms-20-00642" ref-type="bibr" class="xref">24</xref>]; (iii) modify the drug delivery site and/or the time profile [
 <xref rid="B3-ijms-20-00642" ref-type="bibr" class="xref">3</xref>,
 <xref rid="B4-ijms-20-00642" ref-type="bibr" class="xref">4</xref>,
 <xref rid="B5-ijms-20-00642" ref-type="bibr" class="xref">5</xref>]; (iv) reduce or eliminate unpleasant taste and smell [
 <xref rid="B3-ijms-20-00642" ref-type="bibr" class="xref">3</xref>,
 <xref rid="B4-ijms-20-00642" ref-type="bibr" class="xref">4</xref>,
 <xref rid="B5-ijms-20-00642" ref-type="bibr" class="xref">5</xref>]; (v) prevent drug–drug or drug–excipient interactions [
 <xref rid="B4-ijms-20-00642" ref-type="bibr" class="xref">4</xref>]; and (vi) convert liquid drugs into microcrystalline or amorphous powders [
 <xref rid="B13-ijms-20-00642" ref-type="bibr" class="xref">13</xref>].
</p>
